Quarry LP’s AstraZeneca AZN Stock Holding History

Quarry LP’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.9K	Sell	165 -30	-15%	-$5.64K	﹤0.01%	764
2026 Q1	$37.9K	Buy	+195	New	+$37.6K	0.01%	726

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Quarry LP's AZN Position: Q2 2026 in Review

Quarry LP reduced its AstraZeneca (AZN) stake by 15% in Q2 2026, selling an estimated $5.64K and leaving 165 shares worth $30.9K. The position accounts for ﹤0.01% of the portfolio, ranked #764.

Quarry LP first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $37.9K in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Quarry LP held 165 shares of AstraZeneca worth $30.9K as of Q2 2026.
Quarry LP sold 30 AstraZeneca shares in Q2 2026, an estimated $5.64K.
AstraZeneca made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #764 holding.
Quarry LP first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
Quarry LP's AstraZeneca position peaked at $37.9K in Q1 2026.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.